LoConti Joseph E.'s Form 4 filing
Range Impact, Inc. (RNGE) · filed Nov 3, 2023
- Accession no.
- 0001025708-23-000001
- Filed
- Nov 3, 2023
- Trade date
- Oct 30, 2023
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LoConti Joseph E.CIK 0001025708 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2023 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +666,667 | $0.00F1 | $0 | 13,463,813 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2023 | Common Stock | DReturned to the companyDisposed | −6,666,667 | $0.00F1 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Warrants to purchase 6,666,667 shares of Issuer's common stock were exchanged for 666,667 shares of Issuer's common stock in a private transaction entered into between the Reporting Person and Issuer.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.